INCYTE CORP 4

Incyte CEO William Meury received large equity awards on July 16, 2026, including RSUs, performance shares, and stock options on over 180,000 shares of INCY common stock.

On July 16, 2026, Incyte Corporation CEO William Meury received a package of equity compensation awards, including 26,807 shares of common stock in the form of restricted stock units (RSUs), 80,421 performance share units that can pay out up to 200% of one share each based on relative TSR over a three-year performance period ending July 16, 2029, and an employee stock option to purchase 77,148 shares of common stock at an exercise price of $116.65 per share that vests 25% after one year and monthly thereafter over three years. The RSUs vest 25% annually over four years and settle one-for-one in common stock. Following these awards, Meury directly beneficially owns 183,129 shares of common stock (including 178,883 shares underlying unvested RSUs and earned performance stock units). Based on the option exercise price as a proxy for current value, the newly granted RSUs and performance shares represent a grant value of roughly $12.6 million, and his total direct equity exposure in Incyte’s common stock is estimated at about $21.4 million.

Filing Facts

CIK

879169

Ticker

INCY

Form

4

Source Type

fda

Accession

0001536778-26-000009

Alert Tier

7